Viewing nowBialsaltan Tablets 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

MFDS item code 200807881 · Notified 2008.07.17
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
This medication is used for the treatment of hypertension. It is also helpful in treating kidney disease in patients with hypertension who have type 2 diabetes. It helps prevent complications related to hypertension and protects kidney function.
(Tablets) This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be taken orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary for elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with decreased intravascular effective circulating blood volume For patients who may have decreased intravascular effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Children and adolescents 6 years of age and older (1) Patients weighing 20 kg or more and less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. If pregnancy is confirmed, administration should be stopped immediately, and the health status of the fetus and newborn should be closely monitored. This medication should not be administered to patients with specific diseases, such as those allergic to this medicine or its ingredients, severe liver impairment, hereditary angioedema, etc. Moreover, it should be avoided in patients with severely impaired kidney function or when used in combination with certain antihypertensive medications. Caution is required for elderly patients and those with hyperkalemia or liver impairment, as there is a risk of dangerously low blood pressure or worsening kidney function. This medication may have side effects such as muscle cramps, dizziness, upper respiratory tract infections, and, rarely, serious adverse reactions such as angioedema, hepatitis, and rhabdomyolysis. If blood pressure drops sharply or symptoms of renal failure occur, immediate medical attention should be sought. This drug should not be taken together with other potassium-sparing diuretics or potassium supplements, as this can dangerously increase blood potassium levels. Caution is also needed if used with non-steroidal anti-inflammatory drugs (NSAIDs), as this may reduce the blood pressure-lowering effect and worsen kidney function. It is advisable to discontinue use 24 hours before surgery, and regular monitoring of blood pressure, kidney function, and blood potassium levels should be conducted while on this medication. Pregnant and breastfeeding women should not take this medication, and breastfeeding should be avoided or discontinued if taken. This medication is not administered to children, especially those under 6 years of age or patients with severely impaired kidney function. Overdose may result in hypotension and tachycardia, requiring immediate medical attention. While taking this medication, consult with your healthcare provider about pregnancy planning or confirmation, and do not take potassium supplements or salt substitutes containing potassium without consulting your healthcare provider. Keep this medication out of the reach of children and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication must be kept in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain room temperature between 1 to 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.